BRPI0821026A2 - Derivados de alfa-minoamidas úteis no tratamento de transtornos psiquiátricos - Google Patents

Derivados de alfa-minoamidas úteis no tratamento de transtornos psiquiátricos

Info

Publication number
BRPI0821026A2
BRPI0821026A2 BRPI0821026-8A BRPI0821026A BRPI0821026A2 BR PI0821026 A2 BRPI0821026 A2 BR PI0821026A2 BR PI0821026 A BRPI0821026 A BR PI0821026A BR PI0821026 A2 BRPI0821026 A2 BR PI0821026A2
Authority
BR
Brazil
Prior art keywords
minoamide
alpha
treatment
psychiatric disorders
derivatives useful
Prior art date
Application number
BRPI0821026-8A
Other languages
English (en)
Inventor
Emanuela Izzo
Laura Faravelli
Elena Barbanti
Patricia Salvati
Original Assignee
Newron Pharmaceutical S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newron Pharmaceutical S P A filed Critical Newron Pharmaceutical S P A
Publication of BRPI0821026A2 publication Critical patent/BRPI0821026A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BRPI0821026-8A 2007-12-19 2008-12-05 Derivados de alfa-minoamidas úteis no tratamento de transtornos psiquiátricos BRPI0821026A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07024584 2007-12-19
PCT/EP2008/066884 WO2009080470A1 (en) 2007-12-19 2008-12-05 Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders

Publications (1)

Publication Number Publication Date
BRPI0821026A2 true BRPI0821026A2 (pt) 2015-06-16

Family

ID=39310329

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821026-8A BRPI0821026A2 (pt) 2007-12-19 2008-12-05 Derivados de alfa-minoamidas úteis no tratamento de transtornos psiquiátricos

Country Status (15)

Country Link
US (1) US8445539B2 (pt)
EP (1) EP2222290B1 (pt)
JP (1) JP5736175B2 (pt)
KR (1) KR101500962B1 (pt)
CN (1) CN101903021B (pt)
AR (1) AR071278A1 (pt)
AU (1) AU2008340552B2 (pt)
BR (1) BRPI0821026A2 (pt)
CA (1) CA2707646C (pt)
EA (1) EA019529B1 (pt)
ES (1) ES2878063T3 (pt)
IL (1) IL206107A (pt)
NZ (1) NZ586182A (pt)
TW (1) TWI441631B (pt)
WO (1) WO2009080470A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1658062T3 (da) * 2003-08-25 2010-05-31 Newron Pharm Spa Alfa-aminoamid-derivater anvendelige som anti-inflammatoriske midler
HUE030233T2 (en) * 2006-06-19 2017-04-28 Newron Pharm Spa High purity 2- [4- (3- and 2-fluorobenzyloxy) benzylamino] propanamides for use as medicaments and pharmaceutical compositions containing them
SI2563355T1 (sl) 2010-04-27 2016-10-28 Newron Pharmaceuticals S.P.A. Postopek za izdelavo metansulfonatnih soli ralfinamida ali njihovih R-enantiomerov
CN107709314A (zh) 2015-06-11 2018-02-16 巴斯利尔药物国际股份公司 外排泵抑制剂及其治疗性用途
US10407315B2 (en) * 2016-04-14 2019-09-10 Seoul Semiconductor Co., Ltd. Method and/or system for synthesis of zinc oxide (ZnO)
EP3762364B1 (en) 2018-03-08 2023-08-23 Sunshine Lake Pharma Co., Ltd. Pyrrolidineamide derivatives and uses thereof
CN112704678B (zh) * 2020-12-02 2024-02-23 江苏恩华药业股份有限公司 一种丙酰胺衍生物在制备治疗精神分裂症药物中应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94466A (en) 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
EP1032377B1 (en) * 1997-11-21 2010-11-17 Purdue Neuroscience Company Substituted 2-aminoacetamides and the use thereof
AR044007A1 (es) * 2003-04-11 2005-08-24 Newron Pharmaceuticals Inc Metodos para el tratamiento de la enfermedad de parkinson
EP1533295A1 (en) * 2003-11-24 2005-05-25 Newron Pharmaceuticals S.p.A. Cyclopentyl Derivatives
EP1588704A1 (en) * 2004-04-22 2005-10-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
DK1809271T5 (da) * 2004-09-10 2010-12-06 Newron Pharm Spa Anvendelse af (R)-(halogenbenzyloxy)benzylaminopropanamider som natrium- og/eller calciumkanalselektive modulatorer
GB0517740D0 (en) * 2005-08-31 2005-10-12 Novartis Ag Organic compounds
EP1963280B1 (en) 2005-12-22 2015-10-28 Newron Pharmaceuticals S.p.A. 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
EP1870097A1 (en) * 2006-06-15 2007-12-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of cognitive disorders

Also Published As

Publication number Publication date
EA019529B1 (ru) 2014-04-30
IL206107A (en) 2013-10-31
US20110014304A1 (en) 2011-01-20
ES2878063T3 (es) 2021-11-18
AU2008340552A1 (en) 2009-07-02
NZ586182A (en) 2012-02-24
AU2008340552B2 (en) 2013-08-22
KR101500962B1 (ko) 2015-03-10
WO2009080470A1 (en) 2009-07-02
AU2008340552A2 (en) 2010-07-29
EP2222290A1 (en) 2010-09-01
CA2707646A1 (en) 2009-07-02
EP2222290B1 (en) 2021-06-16
TW200934478A (en) 2009-08-16
TWI441631B (zh) 2014-06-21
IL206107A0 (en) 2010-11-30
HK1146221A1 (en) 2011-05-20
US8445539B2 (en) 2013-05-21
CN101903021A (zh) 2010-12-01
EA201070753A1 (ru) 2010-12-30
JP2011506518A (ja) 2011-03-03
JP5736175B2 (ja) 2015-06-17
KR20100102670A (ko) 2010-09-24
CN101903021B (zh) 2012-11-14
CA2707646C (en) 2016-09-13
AR071278A1 (es) 2010-06-09

Similar Documents

Publication Publication Date Title
PL2504005T3 (pl) Zastosowanie pochodnych 1,3-difenyloprop-2-en-1-onu do leczenia zaburzeń wątroby
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
PL1951030T3 (pl) Udoskonalone sposoby i środki do wytwarzania hialuronianu
BRPI0820440A2 (pt) Inibidores aldh-2 no tratamento de desordens psiquiátricas
IL195906A0 (en) Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
ZA200706791B (en) Isoxazole combretasin derivatives for the treatment of disorders
SI3424932T1 (sl) Boronoftalidi za terapevtsko uporabo
LT2894165T (lt) Būdai ir kompozicijos, skirti su komplementu susijusių sutrikimų gydymui
ZA201001264B (en) 1-amino-alkylcycohxane derivatives for the treatment of cochleat tinnitus
IL209336B (en) Compositions for treating hyperproliferative diseases and uses thereof
ZA201005116B (en) 6.7-dialkoxy ouinazoline derivatives useful for treatment of cancer related disorders
DK2173831T3 (da) Brøndbehandling
BRPI0821026A2 (pt) Derivados de alfa-minoamidas úteis no tratamento de transtornos psiquiátricos
ITMI20071915A1 (it) Derivati dell'artemisinina per il trattamento del melanoma
IL209417A0 (en) 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
BRPI0714307A2 (pt) Uso de benzamidas trifluormetil-substituídas no tratamento de distúrbios neurológicos
IL205542A0 (en) Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction
FI20085752A0 (fi) Säädettävä hierontalaite ja menetelmä hierontalaitteen säätämiseksi
GB0725077D0 (en) Antifolate com[ounds for the treatment of melanoma
DK1940447T3 (da) Behandling af neurodegenrative lidelser
SE0501685L (sv) Justerbara hjul
HK1148208A (en) Aldh-2 inhibitors in the treatment of psychiatric disorders
BRPI0716580A2 (pt) Tratamento de distúrbios fibrosantes
GB0724947D0 (en) Composition for the treatment of psychiatric disorders

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B25G Requested change of headquarter approved

Owner name: NEWRON PHARMACEUTICAL S.P.A. (IT)